Pediatric ID

Investigative ID

Global ID

Oral Abstract

297 - Pediatric Viral and Fungal Diseases

Presentations:

• 1:45 PM - 2:00 PM

  2853 - Innate Immune Response in Serum and Cerebrospinal Fluid of Neonates and Infants Infected with Parechovirus-A3 and Enteroviruses
  Rie Habuka, MD – Niigata University; Yuta Aizawa, MD, PhD – Niigata University; Ryohei Izumita, MD, PhD – Niigata University; Hisanori Domon, DDS, PhD – Niigata University; Yutaka Terao, DDS, PhD – Niigata University; Akihiko Saitoh, MD, PhD – Niigata University
• 2:00 PM - 2:15 PM

  2854 - Enterovirus D68 Infections in Pediatric Patients in Central Ohio: Clinical Characteristics of a new Outbreak in 2018.
  Alejandro Diaz, MD – Nationwide Children's Hospital; Huanyu Wang, PhD – Nationwide Children's Hospital; Isabel Torrus, MD – Nationwide Children's Hospital; Fatima Ara Montojo, MD – Nationwide Children's Hospital; Maria Mele-Casas, MD – Nationwide Children's Hospital; Asuncion Mejias, MD, PhD, MsCS – Nationwide Children's Hospital; Amy Leber, PhD – Nationwide Children's Hospital
• 2:15 PM - 2:30 PM

  2855 - Respiratory Syncytial Virus Neutralizing Antibodies in Cord Blood and Serum from Infants up to 2 Years of Age in a Multinational Prospective Study
  Joseph B. Domachowske, MD – SUNY Upstate Medical University; Veronique Bianco, MS – GSK; Ana Ceballos, MD – Instituto Medico Rio Cuarto; Luis Cousin, MD – Tecnologia en Investigación; Ulises D'Andrea, MD – Instituto Medico Rio Cuarto; Ilse Dieussaert, IR – GSK; Janet A. Englund, MD – Seattle Children's Hospital/Univ. of Washington; Sanjay Gandhi, MD – GSK; Gerco Haars, PhD – GSK; Lisa Jose, MBchb – Faculty of Health Sciences, University of the Witwatersrand; Nicola Klein, MD, PhD – Kaiser Permanente Northern California; Joanne M. Langley, MD – Dalhousie University; Amanda Leach, MRCPCH – GSK; Shabir A. Madhi, MBBCh, FCPaeds (SA), PhD – Faculty of Health Sciences, University of the Witwatersrand; Koen Maleux, Bio-Engineer – GSK; Thi Lien-Anh Nguyen, PhD – GSK; Thanyawee Puthanakit, MD – Faculty of Medicine, Chulalongkorn University; Peter Silas, MD – Wee Care Pediatrics; Sonia K. Stoszek, PhD – GSK; Auchara Tangsathapornpong, MD – Faculty of Medicine, Thammasat University; Jamaree Teeratakulpisarn, MD – Khon Kaen University; Miia Virta, MD, PhD – Vaccine Research Center, Tampere University; Khalequ Zaman, MD – International Center for Diarrhoeal Disease Research
• 2:30 PM - 2:45 PM

  2856 - Salvaging High-Value Catheters: Antifungal Lock Therapy for Candidal Central Catheter Infections in a Pediatric Cohort
  Lorne W. Walker, MD, PhD – UPMC Children's Hospital of Pittsburgh; Andrew J. Nowalk, MD, PhD – Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA; UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA
• 2:45 PM - 3:00 PM

  2857 - A Statistical Model to Predict Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation Patients
  Muayad Alali, MD – University of Chicago; Madan Kumar, DO – University of Chicago

Co-Author(s)

• RH

  Rie Habuka, MD

  PhD student
  Niigata University
  Niigata, Niigata, Japan

  Disclosure: Nothing to disclose
• YA

  Yuta Aizawa, MD, PhD

  investigator
  Niigata University
  Niigata, Niigata, Japan

  Disclosure: Nothing to disclose
• VB

  Veronique Bianco, MS

  Statistician
  GSK
  Rockville, MD

  Disclosure: GlaxoSmithKline: Employee, Shareholder
• MK

  Madan Kumar, DO

  Director, Pediatric Antimicrobial Stewardship Service, Associate Director, Pediatric Infectious Diseases Fellowship
  University of Chicago
  Chicago, IL

  Disclosure: Nothing to disclose
• AN

  Andrew Nowalk, MD, PhD

  Associate Professor of Pediatrics
  Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA; UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA
  Pittsburgh, PA

  Disclosure: Nothing to disclose
• HW

  Huanyu Wang, PhD

  Microbiology Laboratory Assistant Director
  Nationwide Children's Hospital
  Columbus, OH

  Disclosure: Nothing to disclose
• AC

  Ana Ceballos, MD

  Dr.
  Instituto Medico Rio Cuarto
  Rio Cuarto, Cordoba, Argentina

  Disclosure: GSK: Grant/Research Support
• RI

  Ryohei Izumita, MD, PhD

  investigator
  Niigata University
  Niigata, Niigata, Japan

  Disclosure: Nothing to disclose
• IT

  Isabel Torrus, MD

  International rotator
  Nationwide Children's Hospital
  Columbus, OH

  Disclosure: Nothing to disclose
• FA

  Fatima Ara Montojo, MD

  International rotator
  Nationwide Children's Hospital
  Columbus, OH

  Disclosure: Nothing to disclose
• LC

  Luis Cousin, MD

  MD/Principal Investigator
  Tecnologia en Investigación
  San Pedro Sula, Cortes, Honduras

  Disclosure: Nothing to disclose
• HD

  Hisanori Domon, DDS, PhD

  associate professor
  Niigata University
  Niigata, Niigata, Japan

  Disclosure: Nothing to disclose
• UD

  Ulises D'Andrea, MD

  Sub-investigator
  Instituto Medico Rio Cuarto
  Rio Cuarto, Cordoba, Argentina

  Disclosure: Nothing to disclose
• MM

  Maria Mele-Casas, MD

  International rotator
  Nationwide Children's Hospital
  Columbus, OH

  Disclosure: Nothing to disclose
• YT

  Yutaka Terao, DDS, PhD

  professor
  Niigata University
  Niigata, Niigata, Japan

  Disclosure: Nothing to disclose
• ID

  Ilse Dieussaert, IR

  Head of Maternal Immunization, GSK Vaccines USA
  GSK
  Rockville, MD

  Disclosure: GSK: Employee
• 

  Asuncion Mejias, MD, PhD, MsCS

  Associate Professor, Pediatrics; Principal Investigator
  Nationwide Children's Hospital
  Columbus, Ohio

  Disclosure: Abbvie: CME lecture, Consultant, Other Financial or Material Support
  Janssen: Grant/Research Support, Other Financial or Material Support
  Roche: Advisory Board, Consultant
• 

  Janet Englund, MD

  Professor
  Seattle Children's Hospital/Univ. of Washington
  Seattle, Washington

  Disclosure: AstraZeneca: Grant/Research Support
  Chimerix: Grant/Research Support
  GlaxoSmithKline: Consultant, Grant/Research Support
  Meissa Vaccines: Consultant
  Merck: Grant/Research Support
  Novavax: Grant/Research Support
  Sanofi Pasteur: Consultant
• AL

  Amy Leber, PhD

  Director, Clinical Microbiology and Immunoserology
  Nationwide Children's Hospital
  Columbus, OH

  Disclosure: BioFire Diagnostics: Grant/Research Support, Advisor or Review Panel member
• SG

  Sanjay Gandhi, MD

  Vice President
  GSK
  Mumbai, Maharashtra, India

  Disclosure: GSK: Employee, Shareholder
• GH

  Gerco Haars, PhD

  Senior Manager Epidemiology
  GSK
  Wavre, Brabant Wallon, Belgium

  Disclosure: GSK: Other Financial or Material Support, employee at time of study start
• LJ

  Lisa Jose, MBchb

  Dr.
  Faculty of Health Sciences, University of the Witwatersrand
  Johannesburg, Gauteng, South Africa

  Disclosure: Nothing to disclose
• NK

  Nicola Klein, MD, PhD

  Director, Kaiser Permanente Vaccine Study Center and Senior Research Scientist
  Kaiser Permanente Northern California
  Oakland, CA

  Disclosure: GlaxoSmithKline: Grant/Research Support
  Merck & Co: Grant/Research Support
  Pfizer: Grant/Research Support
  Protein Science (now Sanofi Pasteur): Grant/Research Support
  Sanofi Pasteur: Grant/Research Support
• JL

  Joanne Langley, MD

  Professor of Pediatrics and Community Health and Epidemiology
  Dalhousie University
  Halifax, NS, Canada

  Disclosure: GSK: Research Grant or Support
  GSK: Research Grant or Support
  Medicago: Research Grant or Support
  PREVENT: Research Grant or Support
  Sanofi: Advisor or Review Panel member
• AL

  Amanda Leach, MRCPCH

  Dr.
  GSK
  Rockville, MD

  Disclosure: GSK: Employee, Shareholder
• SM

  Shabir A. Madhi, MBBCh, FCPaeds (SA), PhD

  Professor of Vaccinology
  Faculty of Health Sciences, University of the Witwatersrand
  Johannesburg, Gauteng, South Africa

  Disclosure: GSK: Grant/Research Support
• KM

  Koen Maleux, Bio-Engineer

  Project Manager
  GSK
  Wavre, Brabant Wallon, Belgium

  Disclosure: GSK: Employee
• TN

  Thi Lien-Anh Nguyen, PhD

  Senior Scientist
  GSK
  Wavre, Brabant Wallon, Belgium

  Disclosure: GSK: Employee, Shareholder
• TP

  Thanyawee Puthanakit, MD

  Associate Professor
  Faculty of Medicine, Chulalongkorn University
  Bangkok, Krung Thep, Thailand

  Disclosure: GSK: Grant/Research Support, Speaker's Bureau
• PS

  Peter Silas, MD

  Principal Investigator
  Wee Care Pediatrics
  Syracuse, UT

  Disclosure: GSK: Independent Contractor
• SS

  Sonia K. Stoszek, PhD

  Dr.
  GSK
  Rockville, MD

  Disclosure: GSK: Employee
• AT

  Auchara Tangsathapornpong, MD

  Associate Professor
  Faculty of Medicine, Thammasat University
  Pathum Thani, Pathum Thani, Thailand

  Disclosure: Nothing to disclose
• JT

  Jamaree Teeratakulpisarn, MD

  Professor
  Khon Kaen University
  Khon Kaen, Khon Kaen, Thailand

  Disclosure: Nothing to disclose
• MV

  Miia Virta, MD, PhD

  Dr.
  Vaccine Research Center, Tampere University
  Tampere, Pirkanmaa, Finland

  Disclosure: Nothing to disclose
• KZ

  Khalequ Zaman, MD

  Dr.
  International Center for Diarrhoeal Disease Research
  Dhaka, Dhaka, Bangladesh

  Disclosure: Nothing to disclose

Moderator(s)

• 

  Paul Sue, MDCM

  Assistant Professor
  UT Southwestern Medical Center
  Dallas, TX
• 

  Benjamin Hanisch, MD

  Assistant Professor
  Children’s National Health System
  Washington, DC

  Disclosure: Nothing to disclose

Presenting Author(s)

• MA

  Muayad Alali, MD

  PID Fellow
  University of Chicago
  Chicago, IL

  Disclosure: Nothing to disclose
• AD

  Alejandro Diaz, MD

  Pediatric ID Fellow
  Nationwide Children's Hospital
  Columbus, OH

  Disclosure: Nothing to disclose
• JD

  Joseph Domachowske, MD

  Dr.
  SUNY Upstate Medical University
  Syracuse, NY

  Disclosure: AstraZeneca: Scientific Research Study Investigator
• LW

  Lorne Walker, MD, PhD

  Pediatric Infectious Diseases Fellow
  UPMC Children's Hospital of Pittsburgh
  Pittsburgh, PA

  Disclosure: Nothing to disclose
• AS

  Akihiko Saitoh, MD, PhD

  Professor
  Niigata University
  Niigata, Niigata, Japan

  Disclosure: Nothing to disclose